Cargando…

Inflammatory markers assessment in an animal model of intracranial hypertension: a randomized trial

BACKGROUND: Intracranial hypertension (ICH) is a common final pathway of most neurosurgical pathologies and leads to poor prognosis if not detected and treated properly. Inflammatory markers have been assessed in clinical scenarios of neurological injuries, in which systemic and brain tissue aggress...

Descripción completa

Detalles Bibliográficos
Autores principales: do Espírito Santo, Marcelo Prudente, Faria, Caroline Silvério, Solla, Davi Jorge Fontoura, Pipek, Leonardo Zumerkorn, Belon, Alessandro Rodrigo, Jeng, Brasil Ping, de Andrade, Almir Ferreira, Teixeira, Manoel Jacobsen, Paiva, Wellingson Silva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380614/
https://www.ncbi.nlm.nih.gov/pubmed/34423394
http://dx.doi.org/10.1186/s40635-021-00408-5
_version_ 1783741232928784384
author do Espírito Santo, Marcelo Prudente
Faria, Caroline Silvério
Solla, Davi Jorge Fontoura
Pipek, Leonardo Zumerkorn
Belon, Alessandro Rodrigo
Jeng, Brasil Ping
de Andrade, Almir Ferreira
Teixeira, Manoel Jacobsen
Paiva, Wellingson Silva
author_facet do Espírito Santo, Marcelo Prudente
Faria, Caroline Silvério
Solla, Davi Jorge Fontoura
Pipek, Leonardo Zumerkorn
Belon, Alessandro Rodrigo
Jeng, Brasil Ping
de Andrade, Almir Ferreira
Teixeira, Manoel Jacobsen
Paiva, Wellingson Silva
author_sort do Espírito Santo, Marcelo Prudente
collection PubMed
description BACKGROUND: Intracranial hypertension (ICH) is a common final pathway of most neurosurgical pathologies and leads to poor prognosis if not detected and treated properly. Inflammatory markers have been assessed in clinical scenarios of neurological injuries, in which systemic and brain tissue aggressions may introduce bias. There is a lack of studies under controlled settings to isolate the ICH effect on inflammation. This study aims to evaluate the effects of ICH on the serum concentration of cytokines as biomarkers of neuroinflammation in an experimental model which isolates ICH from potential confounding variables. METHODS: An established model of ICH using an intracerebral pediatric bladder catheter and a multisensor intraparenchymal catheter was used in adult pigs (Sus domesticus). The animals were randomly allocated to 2 groups based on the catheter balloon volume used to simulate the ICP increase (4 ml or 7 ml). Cytokines were measured in 4 timepoints during the experiment: (1) 15 min before balloon insufflation; (2) 5 min after insufflation; (3) 125 min after insufflation; (4) 60 min after deflation. The following cytokines were measured IL-1α; IL-1β; IL–1ra; IL-2; IL-4; IL-6; IL-8; IL-10; IL-12; IL-18; TNFα. Generalized estimating equations were modeled to compare the ICP and cytokines values between the groups along the experiment. The study sample size was powered to detect interactions between the groups and the study moments with an effect size (f) of at least 0.3. The ARRIVE checklist was followed. RESULTS: A total of 20 animals were studied (10 in each group, 4 ml or 7 ml balloon volume insufflation). The animal model was successful in increasing the ICP along the moments of the experiment (p < 0,001) and in creating an ICP gradient between the groups (p = 0,004). The interaction term (moment × group) was also significant (p < 0,001). There was a significant association between ICP elevation and most cytokines variation. The cytokines IL-1α, IL-1β, IL1-ra, IL-6, IL-12, and IL-18 increased, whereas IL-2, IL-4, and TNF-α decreased. IL-10 did not vary significantly in response to the ICP elevation. CONCLUSION: The serum concentration of cytokines varied in response to intracranial hypertension. The study demonstrated the specific changes in each cytokine after intracranial hypertension and provides key information to guide neuroinflammation clinical research. The proposed experiment was successful as an animal model to the study of neuroinflammation biomarkers SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40635-021-00408-5.
format Online
Article
Text
id pubmed-8380614
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-83806142021-09-08 Inflammatory markers assessment in an animal model of intracranial hypertension: a randomized trial do Espírito Santo, Marcelo Prudente Faria, Caroline Silvério Solla, Davi Jorge Fontoura Pipek, Leonardo Zumerkorn Belon, Alessandro Rodrigo Jeng, Brasil Ping de Andrade, Almir Ferreira Teixeira, Manoel Jacobsen Paiva, Wellingson Silva Intensive Care Med Exp Research Articles BACKGROUND: Intracranial hypertension (ICH) is a common final pathway of most neurosurgical pathologies and leads to poor prognosis if not detected and treated properly. Inflammatory markers have been assessed in clinical scenarios of neurological injuries, in which systemic and brain tissue aggressions may introduce bias. There is a lack of studies under controlled settings to isolate the ICH effect on inflammation. This study aims to evaluate the effects of ICH on the serum concentration of cytokines as biomarkers of neuroinflammation in an experimental model which isolates ICH from potential confounding variables. METHODS: An established model of ICH using an intracerebral pediatric bladder catheter and a multisensor intraparenchymal catheter was used in adult pigs (Sus domesticus). The animals were randomly allocated to 2 groups based on the catheter balloon volume used to simulate the ICP increase (4 ml or 7 ml). Cytokines were measured in 4 timepoints during the experiment: (1) 15 min before balloon insufflation; (2) 5 min after insufflation; (3) 125 min after insufflation; (4) 60 min after deflation. The following cytokines were measured IL-1α; IL-1β; IL–1ra; IL-2; IL-4; IL-6; IL-8; IL-10; IL-12; IL-18; TNFα. Generalized estimating equations were modeled to compare the ICP and cytokines values between the groups along the experiment. The study sample size was powered to detect interactions between the groups and the study moments with an effect size (f) of at least 0.3. The ARRIVE checklist was followed. RESULTS: A total of 20 animals were studied (10 in each group, 4 ml or 7 ml balloon volume insufflation). The animal model was successful in increasing the ICP along the moments of the experiment (p < 0,001) and in creating an ICP gradient between the groups (p = 0,004). The interaction term (moment × group) was also significant (p < 0,001). There was a significant association between ICP elevation and most cytokines variation. The cytokines IL-1α, IL-1β, IL1-ra, IL-6, IL-12, and IL-18 increased, whereas IL-2, IL-4, and TNF-α decreased. IL-10 did not vary significantly in response to the ICP elevation. CONCLUSION: The serum concentration of cytokines varied in response to intracranial hypertension. The study demonstrated the specific changes in each cytokine after intracranial hypertension and provides key information to guide neuroinflammation clinical research. The proposed experiment was successful as an animal model to the study of neuroinflammation biomarkers SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40635-021-00408-5. Springer International Publishing 2021-08-23 /pmc/articles/PMC8380614/ /pubmed/34423394 http://dx.doi.org/10.1186/s40635-021-00408-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Articles
do Espírito Santo, Marcelo Prudente
Faria, Caroline Silvério
Solla, Davi Jorge Fontoura
Pipek, Leonardo Zumerkorn
Belon, Alessandro Rodrigo
Jeng, Brasil Ping
de Andrade, Almir Ferreira
Teixeira, Manoel Jacobsen
Paiva, Wellingson Silva
Inflammatory markers assessment in an animal model of intracranial hypertension: a randomized trial
title Inflammatory markers assessment in an animal model of intracranial hypertension: a randomized trial
title_full Inflammatory markers assessment in an animal model of intracranial hypertension: a randomized trial
title_fullStr Inflammatory markers assessment in an animal model of intracranial hypertension: a randomized trial
title_full_unstemmed Inflammatory markers assessment in an animal model of intracranial hypertension: a randomized trial
title_short Inflammatory markers assessment in an animal model of intracranial hypertension: a randomized trial
title_sort inflammatory markers assessment in an animal model of intracranial hypertension: a randomized trial
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380614/
https://www.ncbi.nlm.nih.gov/pubmed/34423394
http://dx.doi.org/10.1186/s40635-021-00408-5
work_keys_str_mv AT doespiritosantomarceloprudente inflammatorymarkersassessmentinananimalmodelofintracranialhypertensionarandomizedtrial
AT fariacarolinesilverio inflammatorymarkersassessmentinananimalmodelofintracranialhypertensionarandomizedtrial
AT solladavijorgefontoura inflammatorymarkersassessmentinananimalmodelofintracranialhypertensionarandomizedtrial
AT pipekleonardozumerkorn inflammatorymarkersassessmentinananimalmodelofintracranialhypertensionarandomizedtrial
AT belonalessandrorodrigo inflammatorymarkersassessmentinananimalmodelofintracranialhypertensionarandomizedtrial
AT jengbrasilping inflammatorymarkersassessmentinananimalmodelofintracranialhypertensionarandomizedtrial
AT deandradealmirferreira inflammatorymarkersassessmentinananimalmodelofintracranialhypertensionarandomizedtrial
AT teixeiramanoeljacobsen inflammatorymarkersassessmentinananimalmodelofintracranialhypertensionarandomizedtrial
AT paivawellingsonsilva inflammatorymarkersassessmentinananimalmodelofintracranialhypertensionarandomizedtrial